COVID19 reagents
Ended Awarded Last action
- Contract number
- N6264521F0057
- Awardee
-
Gen-Probe Incorporated UEI QNXWLAJDL4J3
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $383,780
Award facts
- Opportunity
-
- Covid-19 Solicitation · N6264520Q0017 · Posted May 12, 2020
- Contract value 100% obligated
- $383,780.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Marlborough, MA 01752, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $383,780 |
About this award
This is a delivery order contract awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company, for COVID-19 reagents. The contract has a ceiling value of $383,780.00 and an ultimate completion date of January 19, 2021. It is a firm fixed-price contract with no set-aside designation. Gen-Probe Incorporated has held numerous federal contracts with various defense and civilian agencies to supply molecular diagnostic testing systems, assays, and related products and services, including for infectious diseases like HIV, hepatitis C, sexually transmitted infections, and COVID-19. The DHA has awarded Gen-Probe an Indefinite Delivery Contract (IDC) with a $15 million ceiling to provide COVID-19 testing services and supplies, while the Department of the Navy Bureau of Medicine and Surgery awarded another IDC with a $9.6 million ceiling for COVID-19 reagents and assays. The Department of Veterans Affairs has also established a Blanket Purchase Agreement (BPA) with Gen-Probe to supply tuberculosis diagnostic reagents and supplies to its medical facilities.
Quick answers
Who was awarded contract N6264521F0057?
N6264521F0057 was awarded to Gen-Probe Incorporated by Bureau of Medicine and Surgery (Department of the Navy) on January 12, 2021.
How much is contract N6264521F0057 worth?
The government has obligated $383,780 on N6264521F0057.
Which agency awarded contract N6264521F0057?
Bureau of Medicine and Surgery (Department of the Navy) awarded N6264521F0057, with funding from Defense Health Agency (Department of Defense).
Is contract N6264521F0057 an order under another contract?
Yes. N6264521F0057 is a delivery order under N6264520D5007, an indefinite delivery contract.
Was contract N6264521F0057 competed?
The extent of competition for N6264521F0057 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award